Dr. Martha Wadleigh, MD
- Medicare services, 2024
- 422
- Medicare patients, 2024
- 137
- Part D claims, 2024
- 166
- MIPS score, 2024
- 84
- Hospital affiliations
- 3
- Practice address
- 450 Brookline Avenue, Boston, MA 02115
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Wadleigh's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Martha Wadleigh is a medical oncologist in Boston, Massachusetts
Dr. Wadleigh practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.
Dr. Wadleigh's NPI, 1972578185, was assigned on February 21, 2006. Dr. Wadleigh graduated from Duke University School of Medicine in 1998. Dr. Wadleigh holds Massachusetts license 209746.
- NPI
- 1972578185NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0547240459
- NPI enumeration date
- February 21, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Martha Wadleigh practices at Dana-Farber Cancer Institute in Boston, Massachusetts
Dr. Wadleigh's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.
- Dana-Farber Cancer Institute450 Brookline Avenue, Boston, MA 02115
Source: Dmand AI Affiliation Data
Dr. Martha Wadleigh is affiliated with 4 sites of care and 1 medical group
Dr. Wadleigh's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Wadleigh is also affiliated with Massachusetts General Hospital. The medical group on file is Binney Medical Group. Dmand AI also links Dr. Wadleigh to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Martha Wadleigh's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wadleigh practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dana-Farber Cancer Institute | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Martha Wadleigh is one of 290 medical oncologists in Massachusetts
Medical oncology is Dr. Wadleigh's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Wadleigh is licensed in Massachusetts.
Specialties and state licenses
- Medical oncology, MassachusettsPrimary
Medical oncologists near Dr. Wadleigh
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Martha Wadleigh billed Medicare for 422 services in 2024
CMS data shows 422 Medicare services from Dr. Wadleigh across 7 procedure codes in 2024, for 137 Medicare patients. Medicare paid $28,894 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Wadleigh's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2572024: 42264%
Dr. Wadleigh compared with the Massachusetts median for medical oncologists, 2024
- Dr. Wadleigh
- Massachusetts median
- Medicare services
- 422vs 26062% above
- Medicare patients
- 137vs 10926% above
- Part D claims
- 73vs 6316% above
Medians across 259 medical oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Wadleigh's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Wadleigh?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Wadleigh and other medical oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Martha Wadleigh treated 137 Medicare patients in 2024, average age 73
CMS counts 137 Medicare patients who saw Dr. Wadleigh in 2024. The largest group is 65 to 74, with 71 patients. 69% of them have high cholesterol, and 68% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Wadleigh's median patient age at 70, with 48% women.
Dr. Wadleigh's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Wadleigh's Medicare patients by sex, 2024
- Women7353%
- Men6447%
Chronic conditions among Dr. Wadleigh's Medicare patients, 2024
- High cholesterol69%
- High blood pressure68%
- Anxiety39%
- Arthritis38%
- Chronic kidney disease36%
- Mood disorders30%
- Atrial fibrillation28%
- Ischemic heart disease28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Wadleigh's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women48%
- Men51%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Martha Wadleigh wrote 166 Medicare Part D claims in 2024
In 2024, Dr. Wadleigh wrote 166 Medicare Part D claims for 29 patients. 55% of them were for generic drugs. CMS names the drug for 73 of them, across 4 drugs with 11 or more claims each, at $842,791 in total drug cost. In 2023, CMS named 143 claims across 8 drugs.
Dr. Wadleigh's Part D claims by kind of drug, 2024
- Generic92 claims55%
- Brand-name74 claims45%
Dr. Wadleigh's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Wadleigh's Part D claims, 2024
- Antibiotics8%13 of 166 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1432024: 7349%
Drugs named by CMS: 4 in 2024, 8 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Martha Wadleigh scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Wadleigh for performance year 2024, reported as part of a group. Dr. Wadleigh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wadleigh as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Wadleigh's MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Martha Wadleigh received $90 in industry payments from 2018 to 2025
CMS Open Payments shows 2 general payments to Dr. Wadleigh from 2 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 52% of the total. Novartis Pharmaceuticals Corporation paid the most, $47. It also lists 3 research payments totaling $4,509 from 2017 to 2024.
General payments to Dr. Wadleigh by program year, 2018 to 2025
General payments to Dr. Wadleigh by kind, 2018 to 2025
- Food and beverage$4752%
- Education$4348%
Companies that paid Dr. Wadleigh the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Martha Wadleigh graduated from Duke University School of Medicine
Dr. Wadleigh graduated from Duke University School of Medicine in 1998.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Martha Wadleigh's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Martha Wadleigh
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Martha Wadleigh's NPI number?
Dr. Martha Wadleigh's NPI number is 1972578185. It was assigned on February 21, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Martha Wadleigh?
Dr. Martha Wadleigh is a medical oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Martha Wadleigh practice?
Dr. Wadleigh practices at 450 Brookline Avenue, Boston, MA 02115. Dr. Wadleigh's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Dr. Wadleigh to 1 hospital and 1 group practice or clinic.
What is Dr. Martha Wadleigh's medical license number?
Dr. Wadleigh holds Massachusetts license 209746.
Which hospitals is Dr. Martha Wadleigh affiliated with?
Dr. Wadleigh practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Wadleigh is also affiliated with Massachusetts General Hospital. Dmand AI links Dr. Wadleigh to 1 more hospital.
What medical group is Dr. Martha Wadleigh part of?
Dr. Wadleigh is linked to Binney Medical Group.
Does Dr. Martha Wadleigh accept Medicare?
Yes. CMS data shows Dr. Wadleigh billed Medicare for 422 services in 2024, and Dr. Wadleigh accepts Medicare assignment.
Does Dr. Martha Wadleigh offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Wadleigh as offering telehealth services.
What is Dr. Martha Wadleigh's MIPS score?
Dr. Wadleigh's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. Martha Wadleigh see?
CMS counts 137 Medicare patients who saw Dr. Wadleigh in 2024, with an average age of 73.
Show 5 more questionsShow fewer questions
What services does Dr. Martha Wadleigh bill to Medicare?
In 2024, Dr. Wadleigh's most billed Medicare services were hospital inpatient care (99232), office visit, established patient (99213) and office visit, established patient (99214).
Where did Dr. Martha Wadleigh go to medical school?
Dr. Wadleigh graduated from Duke University School of Medicine in 1998.
What drugs does Dr. Martha Wadleigh prescribe most?
In 2024 Medicare Part D data, Dr. Wadleigh's most prescribed drugs by claims were Hydroxyurea, Jakafi and Ojjaara.
Has Dr. Martha Wadleigh received payments from drug or device companies?
CMS Open Payments shows $90 in general payments to Dr. Wadleigh from 2 companies from 2018 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Martha Wadleigh been practicing?
Dr. Wadleigh graduated from medical school in 1998, 28 years ago.
Selling to medical oncology practices?
See medical oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card